Solid Developments for Rheumatoid Arthritis (ABT, ARRY, LLY, INCY, JNJ, SGP,...
If you have followed the news on arthritis and rheumatoid arthritis (“RA”) for very long, this was a good week for the possible treatments of the disease. The annual congress of the European League...
View ArticleJPMorgan Issues Coverage on Big Pharma Sector (BMY, LLY, PFE, WYE, MRK, SGP)
JPMorgan has come out with a relatively lackluster coverage in the Big Pharma sector, although not all calls are cautious. Bristol-Myers Squibb (NYSE: BMY), Eli Lilly & Co. (NYSE: LLY), Pfizer Inc....
View ArticleWhat Lies Ahead in Biotech Mergers & Buyouts?
We have been digging around and around for days and weeks in the biotech sector. Our goal is to determine which merger candidates can occur and to gather an opinion of the M&A outlook for 2009....
View ArticlePfizer Tests Waters For Major Acquisitions (PFE, AMGN, WYE, GILD, BMY, LLY,...
It hasn’t taken long for the speculation machine to roll down Wall Street in 2009. A report from the FT over the weekend shows that Pfizer Inc. (NYSE: PFE) is willing to acquire some large rivals. We...
View ArticleMore Evidence Big Pharma Ready To Acquire Biotechs (MRK, PFE, WYE, GILD, BMY,...
We have covered on numerous occasions about how the larger Big Pharma companies either need to or have signaled an openness to making acquisitions in the biotech sector or in the smaller drug...
View ArticleBioHealth Earnings Floodgates Opening (BSX, BIIB, GILD, ISRG, PFE, DGX, SYK,...
Next week is going to be the mother of all earnings reports for the BioHealth community. We have included the key device companies as well in this calendar with the routine top drug and biotech...
View Article
More Pages to Explore .....